1 |
Kalyankumar C, Jamil K (2006). Methylene tetrahydofolate reductase (MTHFR) C677T and A1298C polymorphisms and breast cancer in South Indian population. Int J Cancer Res, 2, 143-51.
DOI
|
2 |
Kan X, Zou T, Wu X, Wang X (2007) . Yunnan methylenetetrahydrofolate reductase gene polymorphism associated with breast cancer susceptibility. Cancer Res, 34, 716-8
|
3 |
Kelsey JL (1993). Breast cancer epidemiology: summary and future directions. Epidemiol Rev, 15, 256-63.
|
4 |
Kim YI (1999). Folate and carcinogenesis: evidence, mechanisms, and implications. J Nutr Biochem, 10, 66-88.
DOI
ScienceOn
|
5 |
Kim YI (2004). Folate, colorectal carcinogenesis, and DNA methylation: lessons from animal studies. Environ Mol Mutagen, 44, 10-25.
DOI
ScienceOn
|
6 |
Kotsopoulos J, Zhang WW, Zhang S, et al (2008). Polymorphisms in folate metabolizing enzymes and transport proteins and the risk of breast cancer. Breast Cancer Res Treat, 8, 9895-6.
|
7 |
Lajin B, Sakur AA, Ghabreau L, Alachkar A (2012). Association of polymorphisms in one-carbon metabolizing genes with breast cancer risk in Syrian women. Tumor Biol, 33, 1133-9.
DOI
ScienceOn
|
8 |
Langsenlehner U, Krippl P, Renner W, et al (2003). The common 677C>T gene polymorphism of methylenetetrahydrofolate reductase gene is not associated with breast cancer risk. Breast Cancer Res Treat, 81, 169-72.
DOI
ScienceOn
|
9 |
Le Marchand L, Haiman CA, Wilkens LR,et al (2004). Kolonel LN, Henderson BE. MTHFR polymorphisms, diet, HRT, and breast cancer risk: the multiethnic cohort study. Cancer Epidemiol Biomarkers Prev, 13, 2071-7.
|
10 |
Lee SA, Kang D, Nishio H, et al (2004). Methylenetetrahydrofolate reductase polymorphism, diet, and breast cancer in Korean women. Exp Mol Med, 36, 116-21.
DOI
ScienceOn
|
11 |
Lewis SJ, Zammit S, Gunnell D, Smith GD (2005).A Meta- Analysis of the MTHFR C677T Polymorphism and Schizophrenia Risk. Am J Med Genet Part B, 135, 2-4.
|
12 |
Li WD, Chen SQ (2009). Association of methylenetetrahydrofolate reductase C677T polymorphism and breast cancer risk. J Prac Med, 25, 2031-3.
|
13 |
Lin J, Spitz MR, Wang Y, et al (2004). Polymorphisms of folate metabolic genes and susceptibility to bladder cancer.: a case -control study. Carcinogenesis, 25, 1639-47.
DOI
|
14 |
Lin WY, Chou YC, Wu MH, et al (2004).The MTHFR C677T polymorphism, estrogen exposure and breast cancer risk: a nested case-control study in Taiwan. Anticancer Res, 24, 3863-8.
|
15 |
Mantel N, Haenszel W (1959). Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst, 22, 719-48.
|
16 |
Liang H, Yan Y, Li T, et al (2013). Methylenetetrahydrofolate reductase polymorphisms and breast cancer risk in Chinese population: a meta-analysis of 22 case-control studies. Tumor Biol, 35, 1695-701.
|
17 |
Liu Y, Zhou LS, Xu XM, et al (2013). Association of dietary intake of folate, vitamin B6 and B12 and MTHFR genotype with breast cancer risk. Asian Pac J Cancer Prev, 14, 5189-92.
DOI
ScienceOn
|
18 |
Ma E, Iwasaki M, Kobayashi M, Kasuga Y, et al (2009). Dietary intake of folate, vitamin B2, vitamin B6, vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case control study in Japan. Nutr Cancer, 61, 447-56.
DOI
|
19 |
Mat thews RG, Sheppard C, Goulding C (1998) . Methylenetetrahydrofolate reductase and methionine synthase: biochemistry and molecular biology. Eur J Pediatr, 157, 54-9.
DOI
|
20 |
Mei Q, Zhou D, Gao J, et al (2012).The association between MTHFR 677C>T polymorphism and cervical cancer: evidence from a meta-analysis. BMC Cancer, 12, 467-76.
DOI
|
21 |
Mir MM, Dar JA, Dar NA, et al (2008). Combined impact of polymorphism of folate metabolism genes; glutamate carboxypeptidase, methylene tetrahydrofolate reductase and methionine synthase reductase on breast cancer susceptibility in Kashmiri Women. In J Health Sciences, 2, 3-14.
|
22 |
Muhammad A, Malik FA, Mahmood Akhtar K (2012). Mutational analysis of the MTHFR gene in breast cancer patients of Pakistani population. Asian Pac J Cancer Prev, 13, 1599-603.
과학기술학회마을
DOI
ScienceOn
|
23 |
Ozen F, Erdis E, Sik E, et al (). Germ-line MTHFR C677T, FV H1299R and PAI-1 5G/4G Variations in Breast Carcinoma. Asian Pac J Cancer Prev, 14, 2903-8.
과학기술학회마을
DOI
|
24 |
Naushad SM, Reddy CA, Rupasree Y, et al (2011).Cross-talk between one-carbon metabolism and xenobiotic metabolism: implications on oxidative DNA damage and susceptibility to breast cancer. Cell Biochem Biophys, 61, 715-23.
DOI
|
25 |
Neumann AS, Lyons HJ , Shen H, et al (2005). Methylenetetrahydrofolate reductase polymorphisms and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Int J Cancer, 115, 131-6.
DOI
|
26 |
Norat T, Aune D, Chan D, Romaguera D (2014). Fruits and Vegetables: Updating the Epidemiologic Evidence for the WCRF/AICR Lifestyle Recommendations for Cancer Prevention. Cancer Treat Res, 159, 35-50.
DOI
|
27 |
Piyathilake CJ, Macakuso M, Johanning GL, et al (2000). Methylenetet rahydrofolate reductase (MTHFR) polymorphism increases the risk of cervical intraepithelial neoplasia. Anticancer Res, 20, 1751-7.
|
28 |
Prasad VV, Wilkhoo H (2011). Association of the functional polymorphism C677T in the methylenetetrahydrofolate reductase gene with colorectal, thyroid, breast, ovarian, and cervical cancers. Onkologie, 34, 422-6.
DOI
|
29 |
Qi J, Miao XP, Tan W, et al (2004). Association between genetic polymorphisms in methylenetetrahydrofolate reductase and risk of breast cancer. Zhonghua Zhong Liu Za Zhi, 26, 287-9.
|
30 |
Rai V, Yadav U, Kumar P (2012) . Prevalence of methylenetetrahydrofolate reductase C677T polymorphism in eastern Uttar Pradesh. Indian J Human Genetics, 18, 43-6.
DOI
|
31 |
Song C, Xing D, Tan W, et al (2001). Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in Chinese population. Cancer Res, 61, 3272-5.
|
32 |
Sangrajrang S, Sato Y, Sakamoto H, et al (2010). Genetic polymorphisms in folate and alcohol metabolism and breast cancer risk: a case-control study in Thai women. Breast Cancer Res Treat, 123, 885-93.
DOI
|
33 |
Shen HB, Xu YC, Zheng YX, et al (2001). Polymorphisms of 5,10- Methylenetetrahydrofolate reductase and risk of gastric cancer in a Chinese population a case-control study. Int J Cancer, 95, 332-6.
DOI
|
34 |
Shrubsole MJ, Gao YT, Cai Q, et al (2004). MTHFR polymorphisms, dietary folate intake, and breast cancer risk: results from the Shanghai Breast Cancer Study. Cancer Epidemiol Biomarkers Prev, 13, 190-6.
DOI
ScienceOn
|
35 |
Song C, Xing D, Tan W, Wei Q, Lin D (2001) . Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res, 61, 3272-5.
|
36 |
Stern LL, Mason JB, Selhub J, et al (2000). Genomic DNA hypomethylation, a characteristic of most cancers, is present in peripheral leukocytes of individuals who are homozygous for the C677T polymorphism in the methylenetetrahydrofolate reductase gene. Cancer Epidemiol Biomarkers Prev, 9, 849-53.
|
37 |
Sturgeon SR, Schairer C, Grauman D, et al (2004). Trends in breast cancer mortality rates by region of the United States, 1950-1999. Cancer Causes Control, 15, 987-95.
DOI
|
38 |
Suzuki T, Matsuo K, Hirose K, et al (2008). One-carbon metabolism- related gene polymorphisms and risk of breast cancer. Carcinogenesis, 2, 356-62.
|
39 |
Wagner C (1995). Biochemical role of folate in cellular metabolism. In: Bailey LB (ed) Folate in health and disease. Marcel Dekker Inc, New York, pp 23-42.
|
40 |
Tu YL, Wang SB, Tan XL (2012). MTHFR gene polymorphisms are not involved in pancreatic cancer risk: a meta-analysis. Asian Pac J Cancer Prev, 13, 4627-30.
과학기술학회마을
DOI
|
41 |
Weiwei Z, Liping C, Dequan L (2014). Association between dietary intake of folate, Vitamin B6, B12 & MTHFR, MTR genotype and breast cancer risk. Pak J Med Sci, 30, 106-10.
|
42 |
Wen YY, Yang SJ , Zhang JX, Chen XY (2013) . Methylenetetrahydrofolate reductase genetic polymorphisms and esophageal squamous cell carcinoma susceptibility: a meta-analysis of case-control studies. Asian Pac J Cancer Prev, 14, 21-5.
과학기술학회마을
DOI
ScienceOn
|
43 |
Wilcken B, Bamforth F, Li Z, et al (2003). Geographical and ethnic var iat ion of the 677C>T al lele of 5,10-methylenetetrahydrofolate reductase (MTHFR): Findings from over 7000 newborns from 16 areas worldwide. J Med Genet, 40, 619-25.
DOI
ScienceOn
|
44 |
Wu Y, Yuan X, Zheng H, et al (2010). Methylenetetrahydrofolate reductase gene c677t single nucleotide polymorphisms and susceptibility to breast cancer research. Modern Oncol, 18, 2375-8.
|
45 |
Wu XY, Ni J, Xu WJ, et al (2012). Interactions between MTHFR C677T-A1298C variants and folic acid deficiency affect breast cancer risk in a Chinese population. Asian Pac J Cancer Prev, 13, 2199-06.
과학기술학회마을
DOI
ScienceOn
|
46 |
Yang X, Lippman ME (1999). BRCA1 and BRCA2 in breast cancer. Breast Cancer Res Treat, 54, 1-10.
DOI
|
47 |
Zhang WB, Zhang JH, Pan ZQ, et al (2012). The MTHFR C677T polymorphism and prostate cancer risk: new findings from a meta-analysis of 7306 cases and 8062 controls. Asian Pac J Cancer Prev, 13, 2597-604.
과학기술학회마을
DOI
|
48 |
Yu CP, Wu MH, Chou YC, Yang T, You SL, Chen CJ, Sun CA: Breast cancer risk associated with multigenotypic poly-Morphisms in folatemetabolizing genes: a nested case-control study in Taiwan. Anticancer Res, 27, 1727-32.
|
49 |
Yuan H, Xu XY, Wang ZL (2009). The relation between polymorphisms of methylenetetrahydrofolate reductase C677T and the risk of breast cancer. J MuDan Jiang Med Univ, 30, 2-4.
|
50 |
Zhang SM, Hankinson SE, Hunter DJ, et al (2005). Folate intake and risk of breast cancer characterized by hormone receptor statuss. Cancer Epidemiol Biomarkers Prev, 14, 2004-8.
DOI
ScienceOn
|
51 |
Zintzaras E (2006). Association of methylenetetrahydrofolate reductase (MTHFR) polymorphisms with genetic susceptibility to gastric cancer: a meta-analysis. J Hum Genet, 51, 618-24.
DOI
|
52 |
Zintzaras E, Hadjigeorgiou GM (2004). The role of G196A polymorphism in the brain-derived neurotrophic factor gene in the cause of Parkinson's disease: a meta-analysis. J Hum Genet, 50, 560-6
|
53 |
Zintzaras E (2007). Maternal gene polymorphisms involved in folate metabolism and risk of Down syndrome offspring: a meta-analysis. J Hum Genet, 52, 943-53.
DOI
|
54 |
Bax L, Yu LM, Ikeda N, et al (2006). Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med Res Methodol, 6, 50.
DOI
|
55 |
Akram M, Malik FA, Kayani MA (2012). Mutational analysis of the MTHFR gene in breast cancer patients of Pakistani population. Asian Pac J Cancer Prev, 13, 1599-603.
과학기술학회마을
DOI
ScienceOn
|
56 |
Alshatwi AA (2010). Breast cancer risk, dietary intake, and methylenetetrahydrofolate reductase (MTHFR) single nucleotide polymorphisms. Food Chem Toxicol, 48, 1881-5.
DOI
|
57 |
Antoniou AC, Pharoah PD, McMullan G, et al (2001).Evidence for further breast cancer susceptibility genes in addition to BRCA1 and BRCA2 in a population-based study. Genet Epidemiol, 21, 1-18.
DOI
ScienceOn
|
58 |
Bailey LB, Gregory JF (1999). Folate metabolism and requirements. J Nutr, 129, 779-82.
|
59 |
Bailey LB (2003). Folate, methyl-related nutrients, alcohol, and the MTHFR 677C!T polymorphism affect cancer risk: intake recommendations. J Nutr, 133, 3748-53.
|
60 |
Boccia S, Hung R, Ricciardi G, et al (2007). Meta- and Pooled Analyses of the Methylenetetrahydrofolate Reductase C677T and A1298C Polymorphisms and Gastric Cancer Risk: A Huge-GSEC Review. Am J Epidemiol, 167, 505-16.
DOI
|
61 |
Botto LD, Yang Q (2000). 5,10-Methylenetetrahydrofolate reductase gene variants and congenital anomalies: a HuGE review. Am J Epidemiol, 151, 862-77.
DOI
ScienceOn
|
62 |
Cam R, Eroglu A, Egin Y, et al (2009). Dihydrofolate reduc-Tase (DHRF) 19-bp intron-1 deletion and methylenetetrahydrofolate reductase (MTHFR) C677T polymorphisms in breast cancer. Breast Cancer Res Treat, 115, 431-2.
DOI
|
63 |
Chen J, Gammon MD, Chan W, et al (2005). One-carbon metabolism, MTHFR polymorphisms, and risk of breast cancer. Cancer Res, 65, 1606-14.
DOI
ScienceOn
|
64 |
Cheng CW, Yu JC, Huang CS, et al (2008). Polymorphism of cytosolic serine hydroxymethyltransferase, estrogen and breast cancer risk among Chinese women in Taiwan. Breast Cancer Res Treat, 111, 145-55.
DOI
|
65 |
Deligezer U, Akisik EE, Dalay N (2005). Homozygosity at the C677T of the MTHFR gene is associated with increased breast cancer risk in the Turkish population. In Vivo, 19, 889-93.
|
66 |
Choi SW, Mason JB (2002). Folate status: effects on pathways of colorectal carcinogenesis. J Nutr, 132, 2413-8.
|
67 |
Colhoun HM, McKeigue PM, Davey Smith G (2003). Problems of reporting genetic associations with complex outcomes. Lancet, 361, 865-72.
DOI
ScienceOn
|
68 |
Collaborative Group on Hormonal Factors in Breast Cancer (1997). Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52 705 women with breast cancer and 108 411 women without breast cancer. Lancet, 350, 1047-59.
DOI
ScienceOn
|
69 |
DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Control Clin Trials, 7, 177-88.
DOI
ScienceOn
|
70 |
Duthie SJ(1999). Folic acid deficiency and cancer: mechanisms of DNA instability. Br Med Bull, 55, 578-92.
DOI
ScienceOn
|
71 |
Egger M, Davey Smith G, Schneider M, Minder C (1997). Bias in meta-analysis detected by a simple, graphical test. BMJ, 315, 629-34.
DOI
ScienceOn
|
72 |
Ergul E, Sazci A, Utkan Z, Canturk NZ (2003). Polymorphisms in the MTHFR gene are associated with breast cancer. Tumour Biol, 24, 286-90.
DOI
ScienceOn
|
73 |
Esteller M, Garcia A, Martinez-Palones JM, et al (1997). Germ line polymoephisms in cytochrome P450 1A1(C4887 CYPIA1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometral cancer susceptibility. Carcinogenesis, 18, 2307-11.
DOI
ScienceOn
|
74 |
Ferlay J, Bray F, Pisani P, Parkin DM (2000). Cancer incidence, mortality and prevalence worldwide. IARC Cancer Base No. 5 [CD-ROM]. Version 1.1. Lyon: IARC Press.
|
75 |
Hekim N, Ergen A, Yaylim I, et al (2007). No association between methylenetetrahydrofolate reductase C677T polymorphism and breast cancer. Cell Biochem Funct, 25, 115-17.
DOI
|
76 |
Friso S, Choi SW, Girelli D, et al (2002). A common mutation in the 5, 10-methylenetetrahydrofolate reductase gene affects genomic DNA methylation through an interaction with folate staus. Proc Natl Acad Sci USA, 99, 5606-11.
DOI
ScienceOn
|
77 |
Frosst P, Bloom HJ, Milos R, et al (1995). A Candidate Genetic Risk Factor for Vascular Disease: a Common Mutation in Methylenetetrahydrofolate Reductase. Nat Genet, 10, 111-3.
DOI
ScienceOn
|
78 |
Gao CM, Tang JH, Cao HX, et al (2009). MTHFR polymorphisms, dietary folate intake and breast cancer risk in Chinese women. J Hum Genet, 5, 414-8
|
79 |
Higgins JP, and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat Med, 21, 1539-58.
DOI
ScienceOn
|
80 |
Hosseini M, Houshmand M, Ebrahimi A (2011). MTHFR polymorphisms and breast cancer risk. Arch Med Sci, 7, 134-7.
|
81 |
Hua Z, Wang Y, Ni J, Ge F, Zou T (2011). Serum folate, vitamin b12 concentration and mthfr, ms gene polymorphism associated with risk of breast cancer research. Mod Oncol, 19, 428-31.
|
82 |
Hulka BS, Stark AT (1995). Breast cancer: cause and prevention. Lancet, 346, 883-7.
DOI
|
83 |
Inoue M, Robien K, Wang R, et al (2008). Green tea intake, MTHFR/TYMS genotype and breast cancer risk: the Singapore Chinese Health Study. Carcinogenesis, 29, 1967-72.
DOI
|
84 |
Jin ZZ, Lu Q, Ge DH, Zong M, Zhu QH (2009). Effect of the methylenetetrahydrofolate reductase gene C677T polymorphism on C-erbB-2 methylation status and its association with cancer. Mol Med Rep, 2, 283-9.
|
85 |
Chou YC, Wu MH, Yu JC, et al (2006). Genetic polymorphisms of the methylenetetrahydrofolate reductase gene, plasma folate levels, and breast cancer susceptibility: a case-control study in Taiwan. Carcinogenesis, 27, 2295-300.
DOI
ScienceOn
|
86 |
Jones PA, Laird PW (1999). Cancer epigenetics comes of age. Nat Genet, 21, 163-7.
DOI
ScienceOn
|
87 |
Jakubowska A, Gronwald J, Menkiszak J, et al (2007). Methylenetetrahydrofolate reductase polymorphisms modify BRCA1-associated breast and ovarian cancer risks. Breast Cancer Res Treat, 104, 299-308.
DOI
|
88 |
Zamora J, Abraira V, Muriel A, et al (2006). Meta-DiSc: a software for meta-analysis of test accuracy data. BMC Medical Research Method, 6, 31.
DOI
|